Sequoia China, HighLight Capital Back $16M Series A Round In US Biotech Start-Up

Login to View

Sequoia Capital China and Chinese healthcare-focused investment firm HighLight Capital have backed a US$16 million series A round of financing in America-based biotechnology company Cullgen Inc., according to a statement released on Wednesday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription